This suggests MCTN‐IRF5 treatment shifts tumors from an immunologically “cold” to “hot” phenotype.[34] We subsequently demonstrated that MCTN‐IRF5 treatment suppressed colorectal tumor growth. This evidence concerns the gene IRF5 and colorectal neoplasm.